The use of high dose d,l-leucovorin in first-line bevacizumab+mFOLFIRI treatment of patients with metastatic colorectal cancer may enhance the antiangiogenic effect of bevacizumab

✍ Scribed by Budai, B.; Nagy, T.; Láng, I.; Hitre, E.

• Book ID: 119955820
• Publisher: Springer
• Year: 2012
• Tongue: English
• Weight: 325 KB
• Volume: 16
• Category: Article
• ISSN: 0969-6970
• DOI: 10.1007/s10456-012-9303-z